MARKET

CSBR

CSBR

Champions Oncolo
NASDAQ
5.10
0.00
0.09%
After Hours: 5.07 -0.03 -0.59% 19:30 09/11 EDT
OPEN
5.17
PREV CLOSE
5.10
HIGH
5.23
LOW
5.00
VOLUME
10.11K
TURNOVER
--
52 WEEK HIGH
8.74
52 WEEK LOW
4.830
MARKET CAP
70.98M
P/E (TTM)
-60.0707
1D
5D
1M
3M
1Y
5Y
1D
Champions Oncology Earnings Call Highlights Margin Momentum
TipRanks · 1d ago
Closing Bell Movers: Oracle up 4% after Q1 earnings beat
TipRanks · 2d ago
Champions Oncology Q1 Adj. EPS $0.05 Up From $0.02 YoY, Sales $15.200M Up From $13.995M YoY
Benzinga · 2d ago
Champions Oncology reports Q1 adjusted EPS 5c vs. 1c last year
TipRanks · 2d ago
Champions Oncology Non-GAAP basic EPS of $0.05, revenue of $15.2M
Seeking Alpha · 2d ago
Weekly Report: what happened at CSBR last week (0831-0904)?
Weekly Report · 6d ago
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026
Barchart · 09/04 10:15
Champions Oncology expands integrated radiopharmaceutical development platform
TipRanks · 09/01 13:20
More
About CSBR
Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is a technology-enabled research organization engaged in creating technology solutions to be utilized in drug discovery and development. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. Its pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development. The Company operates in one segment pertaining to oncology services. Its research platform is a proprietary bank of Patient Derived Xenograft (PDX) models. Its PDX models are deployed into advanced vivo and ex vivo pharmacology platforms, providing an insight into therapeutic programs. The PDX bank is characterized at the molecular, phenotypic and pharmacological levels, which provides a differentiated layer of data for its oncology dataset.

Webull offers Champions Oncology Inc stock information, including NASDAQ: CSBR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSBR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSBR stock methods without spending real money on the virtual paper trading platform.